[Treatment of therapy-resistant hypertension].
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000601:surgery; D006974:Hypertension, Malignant / Q000188:drug therapy / Q000209:etiology; D006977:Hypertension, Renal / Q000601:surgery; D009392:Nephrectomy; D014665:Vasodilator Agents / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D014665:Vasodilator Agents
Behandlung der therapieresistenten Hypertonie.